Article
Tumour necrosis factor gene polymorphisms in lymphoproliferative disease.
Leukemia & lymphoma - 1 Aug 2000
Mainou-Fowler T, Dickinson A M, Taylor P R, Mounter P, Jack F, Proctor S J, Nordon J, Middleton P G
Abstract excerpt
Tumour necrosis factor (TNF) alpha is involved in the pathogenesis of established lymphoproliferative disease. Serum levels of TNFalpha and its soluble receptors are above normal values in B-cell chronic lymphocytic leukaemia (B-CLL) and they are valuable prognostic markers in lymphoma patients. The production of TNFalpha is genetically controlled. Altered synthesis of TNFalpha has been associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
